Floatz logo

Prilocaine

Cognitive Disorder

University of Dublin, Trinity CollegeSmall moleculePhase 1/2Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

131 Active assets in the Cognitive Disorder cohort.

Asset / SponsorPhaseRating
Nicotine
University of Southern California
Phase 2BBB
Oxybutynin
University of Alberta
Phase 4BBB
Quetiapine
Emory University
Phase 4BB
Rivastigmine
VA Office of Research and Development
Phase 4BB
Metformin
Fudan University
Phase 4BB

View all 50 →

Same molecule, other indications

Prilocaine is also rated in:

postherpetic neuralgiaDormant
B
Indicative · Phase 2
57 / 100
View asset →
amnestic disorderActive
CCC
Indicative · Phase 1/2
52 / 100
View asset →
goutDormant
D
Indicative · Unknown
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →